The laboratory of Qianshan Medical Technology (Taizhou). [Photo/WeChat account: weigg6666]
An oral phospholipid gel known as "Parishu", developed by Qianshan Medical Technology (Taizhou), in China Medical City, Taizhou, Jiangsu province, has been approved for listing, bringing a new solution to cancer patients suffering from oral mucosal injury.
In clinical treatment, although radiotherapy and chemotherapy can accurately encircle cancer cells, the accompanying drug side effects can easily lead to damage and ulceration of oral mucosa. The pain of swallowing makes eating an agonizing experience.
"The key to solving this industry challenge lies in building a protective film that firmly adheres to the wound surface," said Pan Haibo, head of the company.
The oral phospholipid gel "Parishu", developed by Qianshan Medical Technology (Taizhou). [Photo/WeChat account: weigg6666]
Unlike the water-soluble polymer materials used in traditional mouthwashes and gel, Qianshan uses phospholipid as the main ingredient. Phospholipids themselves are the main components that make up the human cell membrane. Thin films made from phospholipid can adhere strongly to wounds.
The protective film formed in this way can provide stable protection for 6 to 8 hours, making swallowing, drinking, and eating almost painless, said Pan.